CROSS HERB 4
4 · Jasper Therapeutics, Inc. · Filed Jan 5, 2026
Insider Transaction Report
Form 4
CROSS HERB
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2026-01-02+90,000→ 90,000 totalExercise: $1.84Exp: 2036-01-02→ Voting Common Stock (90,000 underlying)
Footnotes (1)
- [F1]1/4th of the shares subject to the option shall vest on January 2, 2027, and 1/48th of the original number of shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.